Havrix 720 Junior Monodose Vaccine
Havrix 720 Junior Monodose Vaccine is an inactivated Hepatitis A vaccine used to protect children against Hepatitis A virus (HAV) infection. Administered before or shortly after exposure (within two weeks), it helps develop protective immunity by stimulating the body's production of specific antibodies. It is primarily recommended for children and certain at-risk populations.
Contact us for sales assistance from our Biomedical Engineer.
Features:
-
Prevents Hepatitis A in children
-
Contains inactivated Hepatitis A virus
-
Designed specifically for pediatric use (typically <12 years)
-
Can be used for pre- and post-exposure prophylaxis
-
Typically requires a booster dose for extended immunity
-
Administered via intramuscular injection by a healthcare professional
| Technical Specification |
|
|---|
- 0.5 mL pre-filled syringe (PFS)
-
Provides effective protection against Hepatitis A virus
-
Can be administered both pre- and post-exposure
-
Helps control outbreaks in close-contact or endemic settings
-
Suitable for children and immunocompromised individuals
-
Low incidence of side effects and generally well tolerated
-
Supports public health efforts against liver infections
